SMSPHARMA₹414.60-3.28%
50/100
0100 · strongest
good
Weights come from configuration, not from this page — each pillar links to the section below that explains it.
Income stmtHistory
Profitability
headline ratiosGrowth
compounded, from filed annual resultsSegment Results
₹ CrWorking Capital & Efficiency
days · ROCE %SMSPHARMA financial summary
For Mar 2026, SMS Pharmaceuticals Ltd reported revenue of ₹887 crore, which grew 13.3% from the previous year. Net profit was ₹88 crore, which grew 29.4% year on year, on an operating margin of 19%. Earnings per share came in at ₹9.35. Annual results are available for 14 financial years, from Mar 2013 to Mar 2026.
| Revenue | ₹887 crore |
|---|---|
| Net profit | ₹88 crore |
| Operating margin | 19% |
| EPS | ₹9.35 |